University Hospital Ghent University
Recent work (1): A prospective, randomized, factorial design, interventional study to compare the safety and efficacy of combinations of blockade of interleukin-6 pathway and interleukin-1 pathway to best standard. Recent work (2): Treatment of COVID-19 Patients With Anti-interleukin Drugs (COV-AID)
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
Belgium
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership